Specimen/Organism/Date of collection | Antibiotic resistance phenotype by AST | Genotype/Resistance | ||||||
---|---|---|---|---|---|---|---|---|
Sequence type | Î’-lactam antibiotics | Aminoglycosides | Quinolones | Macrolides | Glycopeptides | Other drugs | ||
MDRO screen Enterococcus faecium 29/08/2018 | AMP, LZD, GENS, VAN | C16; E. faecium ST unknown |  | aac(6′)-aph(2″) ant(6)-Ia | parC 80I gyrA 83Y | Erm (B), erm (T) | VanHax | aph(3′)-III Tet(L) |
MDRO screen Escherichia coli 29/08/2018 | AMP, AMC, TZP, AZT, CXM, FEP, FOX, CAZ, CRO, CIP, LVX, GEN, ETP, IPM, MEM, SXT | CP18; E coli ST410 | CMY-2 CTX-M-15 NDM-5 OXA-1 TEM-1B | aac(3)-IId, aac(6′)-Ib-cr aadA5, aph(3″)-Ib aph(6)-Id | aac(6′)-Ib-cr gyrA 83 L gyrA 87 N parC 80I |  |  | dfrA17 sul1, sul2 |
MDRO screen Klebsiella pneumoniae 29/08/2018 | AMK, AMP, AMC, TZP, AZT, CXM, FEP, FOX, CAZ, CRO, CIP, LVX, GEN, ETP, IPM, MEM, SXT | CP19; K. pneumoniae ST2096 | CTX-M-15 OXA-1 OXA-232 SHV-28 TEM-1A | aac(6′)-Ib-cr aadA2 armA | aac(6′)-Ib-cr oqxAB gyrA 83Y gyrA 87G parC 80I |  |  | dfrA1, dfrA12, dfrA14 sul1 tet(L) |
Urine Enterococcus faecium 09/09/2018 | AMP, LZD, GENS, VAN, CIP, NIT, TET | C17; E. faeceum ST80 |  | aac(6′)-aph(2″) aph(3′)-III | gyrA 83I parC 80I | erm(A), erm(B), erm(T) | VanHAX | tet(L) |
Blood (PICC line) Escherichia coli 26/03/2019 | AMK, AMP, AMC, TZP, AZT, CFZ, CFL, CXM, FEP, FOX, CAZ, CRO, CIP, LVX, GEN, ETP, IPM, MEM, SXT, CZA, C/T, FOF | CP48; E. coli ST405 | blaNDM-5 blaTEM-1B | aadA2 | gyrA 83 L gyrA 87 N parC 80I | erm(B) |  | dfrA12 sul1 |
Blood (peripheral) Klebsiella pneumonaie 06/04/2019 | AMK, AMP, AMC, TZP, AZT, CXM, FEP, FOX, CAZ, CRO, CIP, LVX, GEN, ETP, IPM, MEM, SXT, FOF, TGC, CST | C12; K pneumoniae ST395 | CTX-M-15 NDM-5 OXA-1 OXA-232 SHV-11 TEM-1B | aac(6′)-Ib-cr aadA2 aph(6)-Id rmtB strA | aac(6′)-Ib-cr oqxAB gyrA 83I parC 80I | erm(B) |  | dfrA12 dfrA7 sul1 |
Blood (port a cath) Elizabethkingia meningoseptica 06/04/2019 | AMK, AZT, FEP, CAZ, CRO, GEN, IPM, MEM | C11R; E. meningoseptica | B-14 GOB-1 | Â | Â | Â | Â | CME-2 |